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should assist the physician in identifying those patients who are likely to benefit from
revascularization without undue risk.
1080-66 How Efficacious Is Vascular Brachytherapy for the 
Treatment of Ostial In-stent Restenosis?
Eric Eeckhout, Christian Roguelov, Edoardo De Benedetti, Phillippe Coucke, CHUV, 
Lausanne, Switzerland
Background : Percutaneous intervention for ostial coronary disease remains a therapeu-
tic challenge with a trend towards more restenosis. Vascular brachytherapy (VBT) is the
only proven therapy for in-stent-restenosis (ISR). Methods : We sought to evaluate the
efficacy of VBT for ostial ISR based on data extracted from the largest registry on beta
VBT using the Betacath system (Novoste, Norcross, USA).
Results : Out of 878 pts treated by VBT for ISR, 47 presented with ostial ISR. Baseline
clinical, angiographic and procedural data were comparable for both groups except for
vessel size and mean dose (3.16±0.50mm (all, Group 1) vs 3.33±0.52mm (ostial, Group
2) and 18.8±3.10Gy (Group1) vs 23.31±3.90Gy (Group 2), respectively, p<0.05). In par-
ticular in Group 2, vessel type was the left main (10%), the LAD (24%), the Lcx (24%),
the RCA (30%) and a vein graft (12%). Ostial location was aorto-coronary in 51% of
cases, while 49% was coronary-ostial. Technical success was comparable : 96% for
Group 1 and 95% for Group 2 (p=NS). Additional stent use was also similar : 29% (Group
1) vs 35% (Group ). At hospital discharge, myocardial infarction (MI) rate was higher in
the ostial group (0.7% (Group1)vs 2.1% (Group2), p<0.05) and as a potential conse-
quence mortality was higher at 6 months (1.8% (Group 1) vs 6.4% (Group 2), p <0.05).
The overall incidence of adverse events however was comparable (17.9% (Group 1) vs
12.8% (Group2), p=NS).
In conclusion : VBT seems feasible and efficacious in reducing recurrent ISR. However,
potentially because of technical issues, the MI rate is higher during intervention than in a
general ISR population. Consequently, at 6 months follow-up, mortality is also higher.
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1081-47 The Benefit of Coronary Stenting in Small Vessels Is 
Dependent on Reference Vessel Diameter: Results 
From a Meta-Analysis of 11 Randomized Trials
Raul Moreno, Cristina Fernandez, Rosana Hernandez-Antolin, Maria J. Perez-Vizcayno, 
Fernando Alfonso, Javier Escaned, Manel Sabaté, Camino Bañuelos, Carlos Macaya, 
Hospital Clinico San Carlos, Madrid, Spain
Background: The benefit of coronary stenting (CS) in small vessels is still under debate,
since results from randomized studies have yielded controversial results. The aim of this
study was to evaluate the influence of reference vessel diameter (RVD) on the effect of
CS in restenosis in small vessels.
Methods: A meta-analysis including eleven randomized trials on CS versus balloon
angioplasty (BA) in small (<3mm) vessels was performed. A lineal regression equation
was used to evaluate the association between mean RVD and the benefit of CS (RR for
restenosis).
Results: Overall, 3,541 patients were included (1,672 allocated to BA and 1,869 to CS).
Of them, 2,977 (84%) had angiographic re-evaluation at 6 months. RVD at baseline was
similar in patients allocated to BA and CS (2.35 vs. 2.36 mm, p=NS). The pooled rest-
enosis rate was 25.8% and 34.2% in patients allocated to CS and BA, respectively
(p<0.001; risk ratio 0.75; 95% confidence interval 0.67-0.84) [absolute risk reduction
0.07, 95%CI 0.02-0.13, p=0.005]. A smaller RVD at baseline was associated with higher
risk reduction of restenosis (y = - 3.551 + 1.826 [x]; p=0.012) (see figure).
Conclusion: Elective stenting is superior to provisional stenting in small coronary arter-
ies. This benefit is more evident in vessels with smaller RVD.
1081-48 Latin America Small Vessel Randomized Study in 
Diabetic Patients (LASMAL II): Clinical and 
Angiographic Follow-Up Data
Alfredo E. Rodriguez, Maximo Rodriguez Alemparte, Carlos Fernandez Pereira, Victor 
Bernardi, Cesar F. Vigo, Claudio Llaurado, Alberto Sampaolessi, Rocha Loures Bueno, 
The LASMAL investigators, Otamendi Hospital, Buenos Aires, Argentina, Clinica IMA, 
Adrogue, Argentina
Background: There are several randomized studies comparing stent vs PTCA in
patients (pts) with small vessel reference size, however at our knowledge there were no
previous randomized comparison in diabetic pts between PTCA and stents in a popula-
tion with small reference vessel size.
Methods: From February 2001 to July 2003, 220 diabetic pts presenting severe lesion in
small native coronary artery (<2.9 mm) and clinical indication of myocardial revascular-
ization were included in this study . In 9 Latin America centers , pts were randomized to
an initial strategy to PTCA (109) or elective stent therapy (111). A coated posphorylcho-
line small vessel stent (Abbott-BiodivYsio SV) was used in stent arm , lesions in stent
group were always treated previously with conventional balloon technique. The end point
of the study was to compare angiographic binary restenosis, minimal luminal diameter,
net gain,target vessel revascularization (TVR) , target vessel failure (TVF) and major
adverse cardiovascular events(MACE) at six month of follow up between both revascular-
ization strategies.
Results:Both groups had similar baseline, clinical demographic and angiographic char-
acteristics ( Diabetes type II in 92%).After randomization in PTCA group, 24% of the pts
crossed over to stent during the initial procedure. A bolus and 12 hours infusion of abcix-
imab was given in 41% of pts in both groups.Hospital and 30 days outcome were similar
in PTCA and stent group ( MACE 11% vs 7% respectively p=ns ) Long term clinical follow
up ( 12.8+ 8 months) was obtained in 98% of the pts. Six months follow up angiogram
was available in 73% of them. There were no significant differences in TVR ( PTCA
15.6% vs Stent 14.4% p= ns) or incidence of MACE ( PTCA 22.3% vs Stent 18% p= ns)
between both groups whereas TVF ( PTCA 34% vs Stent 18.8% p<0.05) angiographic
restenosis ( PTCA 45% vs Stent 28.5% p<0.043) and net gain ( PTCA 0.74mm vs Stent
0.94mm p= 0.008) were significantly better with stent therapy.Conclusions: This multi-
center randomized study demostrated that an initial strategy with a small vessel stent
design in diabetic pts had a long term follow up lower angiographic restenosis, TVF and
better net gain than those initially treated with PTCA.
1081-49 T-Stenting of Bifurcation Lesions Is Associated With a 
High Incidence of Stent Thrombosis
Francois Gobeil, Chantal Tremblay, Francois Reeves, Guy Leclerc, Roger-Marie Gagnon, 
Alain Rivard, Stephane Rinfret, Notre-Dame Hospital, CHUM, Montreal, PQ, Canada
Background: Bifurcation treatment remains a technical challenge. Stenting of both main
and side branches is associated with good acute angiographic result, but it’s impact on
the risk of stent thrombosis is unknown.
Methods: Between 12-2001 and 01-2003, a total of 96 patients underwent stenting of a
bifurcation lesion at our institution. Baseline and procedure-related data were prospec-
tively collected.
Results: Acute coronary syndrome was the indication for PCI in 88% of patients. Most
lesions involved the LAD-diagonal bifurcation (54%). In 20 patients (21%), 2 stents (2S)
were implanted (T-stenting), mostly because of a residual lesion in the side branch. In the
remaining patients, only one stent (1S) was used. Baseline demographic data were bal-
anced between both groups. Clopidogrel pre-treatment and use of IIbIIIa inhibitors were
similar. There was no difference in mean stent diameter (3.1+ 0.3 mm vs 3.1+ 0.4 mm,
2S vs 1S) and length (20+ 6 mm vs 18+ 6 mm) implanted in the main branch. Stents
were all deployed at 13 + 2 atm. Mean stent diameter and length in the side branch
(group 2S) was 2.6+ 0.4 mm and 12.3+ 0.4 mm respectively. Final kissing balloon infla-
tion was performed in the majority (85% vs 77%, 2S vs 1S, p= 0.45). Side branch resid-
ual stenosis (RS) was significantly lower in the 2S group (4+ 8% vs 19+ 19%, p< 0.001).
However, angiographic success (RS < 30% with stent, RS < 50% without stent, and TIMI
